The Risks and Rewards of Rare Diseases
February 28, 2025
Bluebird bio’s financial situation is a stark reminder of the challenges of developing advanced therapies for rare diseases.
4 min read

February 28, 2025
Bluebird bio’s financial situation is a stark reminder of the challenges of developing advanced therapies for rare diseases.
4 min read
February 28, 2025
To shareholders – according to an analysis of financial reports from healthcare companies.
2 min read
February 27, 2025
How connecting the data dots can lead to better development and clinical trials.
4 min read
February 26, 2025
A Lassa fever vaccine candidate shows promise in animal studies, with guinea pigs 100 percent protected from lethal virus exposure.
7 min read
February 26, 2025
How precision analytics is driving the future of pharmaceuticals, from small molecules to CRISPR gene editing.
5 min read
February 25, 2025
How do you scale up operations without adding headcount or significantly increasing investment in instrumentation? The answer: automation and workflow scheduling software.
6 min read
February 25, 2025
A regulatory science push in the UK includes centres for digital transformation, AI and more.
3 min read
February 25, 2025
How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.
3 min read
February 24, 2025
The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.
3 min read
February 24, 2025
Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards
3 min read
False
False